C

Camurus

Sustainability Report and Carbon Intensity Rankings

Is Camurus doing their part?

Their DitchCarbon score is 48

Camurus has a DitchCarbon Score of 48 out of 100, indicating moderate performance in sustainability practices. This score reflects the company’s current carbon intensity level, suggesting there is significant room for improvement in reducing emissions. A higher score would demonstrate a stronger commitment to lowering carbon intensity and enhancing environmental sustainability.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Camurus is part of the industrial manufacturing sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Medium

High

Very high

Camurus is located in Sweden, a country with a very low carbon intensity rating. This suggests that the company’s operations benefit from the nation’s strong sustainability efforts and clean energy usage.

Unlock 30+ emissions intelligence data points

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on Camurus

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

6.71%

...this company is doing 6.71% better in emissions than the industry average.

Camurus, founded in 1991, is a Swedish pharmaceutical company located in Lund, operating within the industrial manufacturing sector. The company specializes in developing and commercializing innovative medicines for severe and chronic conditions, utilizing its proprietary FluidCrystal drug delivery technologies. Camurus maintains a clinical pipeline that addresses cancer, endocrine diseases, pain, and addiction, and is publicly traded on Nasdaq Stockholm.

Compare Camurus with other companies in the same industry –>

emission intelligence's platform recommendations for Camurus

Camurus should foster partnerships with industry peers to exchange best practices and resources, enhancing their collective ability to diminish Scope 3 emissions.

Bad news, Camurus hasn't committed to SBTi goals yet

Camurus has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company has not defined or announced clear goals for reducing greenhouse gas emissions in line with climate science.

Not participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Other company reports in this industry

Looking for a specific company?

Search our company directory or contact us for custom data requests.

C

Camurus

Sustainability Report and Carbon Intensity Rankings

Is Camurus doing their part?

Their DitchCarbon score is 48

Industry emissions intensity

Very low

Low

Medium

High

Very high

Location emissions intensity

Very low

Low

Medium

High

Very high

Unlock 30+ emissions intelligence data points

Unlock 30+ emissions data points on Camurus

...this company is doing 6.71% better in emissions than the industry average.

emission intelligence's platform recommendations for Camurus

Bad news, Camurus hasn't committed to SBTi goals yet

Claim this profile

Our methodology

Other company reports in this industry

Looking for a specific company?

Quicklinks

Resources

Get in touch